An MDS diagnosis can be highly complex, with subtle chromosomal differences indicating different syndromes and classifications. At Moffitt Cancer Center in Tampa, Florida, we have extensive experience in diagnosing and treating the full range of myelodysplastic syndromes, from the more common types to the seldom-seen diagnoses. Moffitt is not only a high-volume cancer center based on patient volume, but also home to one of the most robust and sophisticated malignant hematology programs in the nation.
Moffitt’s malignant hematology team understands that the key to successful myelodysplastic syndrome treatment lies in the ability to establish a proper MDS diagnosis. Each syndrome is highly unique, and treatment is dependent on the molecular and chromosomal analysis that occurs throughout the evaluation process. Our highly advanced diagnostic approach combines the expertise of numerous disciplines, including:
- Molecular biology
Once an MDS diagnosis is established, our experienced physicians work as a collaborative group to guide each patient’s individualized treatment. Our treatment protocols are integrated with those of the Blood and Marrow Transplantation Program, and we have capabilities for both inpatient and outpatient chemotherapy administration at several locations throughout Tampa. Depending on the specifics of a patient’s MDS diagnosis, we may also be able to recommend one of our advanced clinical trials as another potential treatment option.
We welcome patients who do not yet have a confirmed MDS diagnosis, as well as those who have been diagnosed with a myelodysplastic syndrome and are seeking a second opinion from a Tampa, FL, area specialist. Referrals are never required at Moffitt. To schedule an appointment, call 1-888-663-3488 or submit a new patient registration form online.